Frank D’Amelio: Ellman International
Rosalind Hill talks to Frank D’Amelio, CEO of Ellman International, Inc., about the issues currently facing the aesthetic industry, and what we should be doing to ensure public confidence remains
Read MoreAuthor: Rosalind Hill
Should cosmetic surgery advertising be banned?
During September, the British Association of Aesthetic Plastic Surgeons (BAAPS) announced their proposals for a new, strict, advertising code. While the BAAPS are continuing their campaign for an outright ban...
Read MoreNeil Wolfenden: Cynosure
Rosalind Hill talks to Neil Wolfenden about his passion for the aesthetic laser industry, and why customer satisfaction should always be at the centre of everything we do.
Read MoreFacebook: using it for the benefit of your practice
Wendy Lewis explains the best ways in which to harness the power of Facebook for your clinic, as well as rules to follow and pitfalls to avoid
Read MoreShining the light and getting the message on breast reconstruction
Plastic surgery is not all about privately-funded elective procedures, as the example of breast reconstruction after a mastectomy shows. This particular procedure also suffers low awareness levels, but new — and new age — initiatives are helping bring it out into the open. Ashley Yeo reports
Read MoreBarbara Green: NeoStrata
Rosalind Hill talks to Barbara Green, VP of Clinical Affairs and Technology at NeoStrata, about current research at the company, as well as thoughts on the future of skincare
Read MoreThe power of light: leveraging innovative technologies
Wendy Lewis discusses the advantages of introducing new technologies to your clinic, and why effective marketing is paramount to reap the benefits
Read MoreLearning from experience: Europe puts its house in order
Crisis management it may be, but the EU is working hard in the wake of the PIP scandal to get its house in order as far as cosmetic surgery regulation and standard-setting are concerned. Opinion is divided as to the best course to take, but the consensus now is that the opportunity to establish a regulatory basis must not be missed. Ashley Yeo reports
Read More
March/April 2024 Issue
